US approves first drug for rare erection disorder | Inquirer Business

US approves first drug for rare erection disorder

/ 09:08 AM December 07, 2013

WASHINGTON — The Food and Drug Administration has approved the first drug to treat an unusual condition that causes painful, curved erections in men.

The agency says it approved the biotech drug Xiaflex to treat Peyronie’s disease, which causes an abnormal bend in the penis during erection. The disease is caused by scar tissue and can lead to pain and other difficulties during sex.

The FDA says the injectable drug is the first non-surgical treatment for the disease.

Article continues after this advertisement

Drugmaker Auxilium Pharmaceuticals estimates 5 percent of U.S. men are affected.

FEATURED STORIES

The FDA said it is limiting distribution of the drug to certified physicians and health care centers due to serious potential side effects, including injury of the penis. Health care professionals must enroll and complete a training program before prescribing the drug.

RELATED STORIES:

Article continues after this advertisement

Hardness more important than size or frequency

More sex, please – we’re avoiding erectile dysfunction

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Erectile Dysfunction, Health Science, Sex

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.